DESENTUM

desentum-logo

Desentum is a research-oriented biopharmaceutical company specialized in developing novel types of allergy vaccines that are based on switching the immune system's response to allergens from hypersensitivity to tolerance. They have a unique approach for designing allergy vaccines. By studying the molecular mechanism of the hypersensitivity reaction, they have made discoveries that allow for improved design of vaccines against common types of allergies. Their goal is to provide long-term relief for patients suffering from allergic symptoms, as well as reduce the social and economic burden allergies cause to both individuals and society.

#SimilarOrganizations #People #Financial #Website #More

DESENTUM

Social Links:

Industry:
Biotechnology Pharmaceutical

Founded:
2011-01-01

Address:
Espoo, Southern Finland, Finland

Country:
Finland

Website Url:
http://www.desentum.fi

Total Employee:
1+

Status:
Active

Contact:
+358500512934

Email Addresses:
[email protected]

Total Funding:
17.69 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Tag Manager Content Delivery Network Apache Euro US Privacy User Signal Mechanism YouTube Pound Sterling Japanese Yen


Similar Organizations

advanced-cell-diagnostics-logo

Advanced Cell Diagnostics

Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.

advaxis-logo

Advaxis

Advaxis is a developer of multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer.

fulcrum-therapeutics-logo

Fulcrum Therapeutics

Fulcrum Therapeutics is a biotechnology company that develops new medicines to treat patients with rare genetic diseases.

imvax-logo

Imvax

Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies.

oncohost-logo

OncoHost

OncoHost is a clinical-stage biotechnology company developing personalized strategies to increase the success of cancer therapy.

paxvax-logo

PaxVax

PaxVax is a start-up developing candidate oral vaccines for key infectious diseases.

Current Employees Featured

pekka-mattila_image

Pekka Mattila
Pekka Mattila CEO @ Desentum
CEO
2011-08-01

Founder


pekka-mattila_image

Pekka Mattila

Investors List

springvest_image

Springvest

Springvest investment in Venture Round - Desentum

european-innovation-council_image

European Innovation Council

European Innovation Council investment in Grant - Desentum

springvest_image

Springvest

Springvest investment in Series A - Desentum

vtt-ventures_image

VTT Ventures

VTT Ventures investment in Series A - Desentum

sto-rahoitus_image

Sto-Rahoitus

Sto-Rahoitus investment in Series A - Desentum

luxembourgian-acme-investments_image

Luxembourgian ACME Investments

Luxembourgian ACME Investments investment in Series A - Desentum

cascara-ventures_image

Cascara Ventures

Cascara Ventures investment in Series A - Desentum

Official Site Inspections

http://www.desentum.fi

  • Host name: fi-f2.seravo.net
  • IP address: 95.217.44.205
  • Location: Finland
  • Latitude: 60.1717
  • Longitude: 24.9349
  • Timezone: Europe/Helsinki

Loading ...

More informations about "Desentum" on Search Engine